ESG10 Jul 2026, 05:20 pm
Zydus Lifesciences Files FY26 Business Responsibility and Sustainability Report
AI Summary
Zydus Lifesciences Limited has submitted its Business Responsibility and Sustainability Report for the financial year ended March 31, 2026. The report, filed as per SEBI regulations, details the company's corporate identity, business activities in pharmaceuticals (82.56% turnover), consumer wellness (14.56%), and medical devices (2.88%). It also outlines operational locations, market reach across 81 countries, employee statistics, and sustainability initiatives. The company obtained reasonable assurance from M/s SGS India Private Limited for this report.
Key Highlights
- FY26 Business Responsibility and Sustainability Report filed.
- Pharmaceuticals dominate turnover at 82.56%.
- Operations span 64 national and 54 international locations.
- Exports contribute 33.80% to total turnover.
- Report assured by SGS India Private Limited.
Price Impact
More from ZYDUSLIFE